

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.47685219 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.99426402 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.99426402 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.37057182 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.88526107 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.85815630 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 5.43225141 |
| 8 | negative T cell selection (GO:0043383) | 5.35806951 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.35463305 |
| 10 | negative regulation of cell killing (GO:0031342) | 5.35463305 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.30041504 |
| 12 | leukocyte aggregation (GO:0070486) | 5.27375070 |
| 13 | negative thymic T cell selection (GO:0045060) | 5.19886297 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.14661594 |
| 15 | response to interleukin-15 (GO:0070672) | 4.95810467 |
| 16 | cellular response to interleukin-15 (GO:0071350) | 4.85435180 |
| 17 | positive thymic T cell selection (GO:0045059) | 4.84395937 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.59461662 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.59461662 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 4.59461662 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 4.59461662 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 4.59461662 |
| 23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.59461662 |
| 24 | regulation of B cell differentiation (GO:0045577) | 4.57253731 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 4.56634729 |
| 26 | interferon-gamma production (GO:0032609) | 4.40320650 |
| 27 | thymic T cell selection (GO:0045061) | 4.34714889 |
| 28 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.32127967 |
| 29 | positive T cell selection (GO:0043368) | 4.28649354 |
| 30 | detection of other organism (GO:0098543) | 4.25268827 |
| 31 | mast cell activation (GO:0045576) | 4.19304434 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 4.17071931 |
| 33 | neutrophil activation involved in immune response (GO:0002283) | 4.13887950 |
| 34 | detection of bacterium (GO:0016045) | 4.12215315 |
| 35 | T cell selection (GO:0045058) | 4.11883610 |
| 36 | T cell migration (GO:0072678) | 4.09475521 |
| 37 | B cell receptor signaling pathway (GO:0050853) | 4.09245566 |
| 38 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.05348509 |
| 39 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.04621136 |
| 40 | response to peptidoglycan (GO:0032494) | 4.04304783 |
| 41 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.96876086 |
| 42 | macrophage activation involved in immune response (GO:0002281) | 3.94431690 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 3.93525740 |
| 44 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.92663056 |
| 45 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.90943025 |
| 46 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.84519725 |
| 47 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.79820370 |
| 48 | T cell homeostasis (GO:0043029) | 3.75335462 |
| 49 | T cell receptor signaling pathway (GO:0050852) | 3.74123611 |
| 50 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.64127977 |
| 51 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.60083759 |
| 52 | T cell costimulation (GO:0031295) | 3.59866342 |
| 53 | lymphocyte costimulation (GO:0031294) | 3.55088291 |
| 54 | ribosomal small subunit assembly (GO:0000028) | 3.54283214 |
| 55 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.53928555 |
| 56 | response to muramyl dipeptide (GO:0032495) | 3.53722131 |
| 57 | detection of external biotic stimulus (GO:0098581) | 3.49737797 |
| 58 | neutrophil activation (GO:0042119) | 3.48396835 |
| 59 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.47158926 |
| 60 | negative regulation of phagocytosis (GO:0050765) | 3.46616066 |
| 61 | mast cell degranulation (GO:0043303) | 3.44567551 |
| 62 | mast cell activation involved in immune response (GO:0002279) | 3.44567551 |
| 63 | regulation of tolerance induction (GO:0002643) | 3.44155189 |
| 64 | tolerance induction (GO:0002507) | 3.43921790 |
| 65 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.40117616 |
| 66 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.39742392 |
| 67 | regulation of T cell tolerance induction (GO:0002664) | 3.39646055 |
| 68 | positive regulation of granulocyte differentiation (GO:0030854) | 3.35420846 |
| 69 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.34773491 |
| 70 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.34773491 |
| 71 | myeloid cell activation involved in immune response (GO:0002275) | 3.34305169 |
| 72 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.32875141 |
| 73 | activated T cell proliferation (GO:0050798) | 3.32621987 |
| 74 | granulocyte activation (GO:0036230) | 3.32380022 |
| 75 | megakaryocyte development (GO:0035855) | 3.30214594 |
| 76 | respiratory burst (GO:0045730) | 3.29715717 |
| 77 | germinal center formation (GO:0002467) | 3.27669151 |
| 78 | myeloid dendritic cell activation (GO:0001773) | 3.27290760 |
| 79 | positive regulation of interleukin-2 production (GO:0032743) | 3.27147341 |
| 80 | response to host immune response (GO:0052572) | 3.26570708 |
| 81 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.26570708 |
| 82 | immunoglobulin mediated immune response (GO:0016064) | 3.26432286 |
| 83 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.26017419 |
| 84 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.25869757 |
| 85 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.24575713 |
| 86 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.24575713 |
| 87 | mature B cell differentiation (GO:0002335) | 3.22527272 |
| 88 | regulation of response to interferon-gamma (GO:0060330) | 3.20651356 |
| 89 | detection of molecule of bacterial origin (GO:0032490) | 3.20542291 |
| 90 | lymphocyte homeostasis (GO:0002260) | 3.19745966 |
| 91 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.18440631 |
| 92 | Peyers patch development (GO:0048541) | 3.18440631 |
| 93 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.17983257 |
| 94 | mature B cell differentiation involved in immune response (GO:0002313) | 3.17483679 |
| 95 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.17386805 |
| 96 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.16645455 |
| 97 | NIK/NF-kappaB signaling (GO:0038061) | 3.16457072 |
| 98 | B cell mediated immunity (GO:0019724) | 3.16249219 |
| 99 | cellular extravasation (GO:0045123) | 3.15297847 |
| 100 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.14271446 |
| 101 | detection of biotic stimulus (GO:0009595) | 3.13982175 |
| 102 | definitive hemopoiesis (GO:0060216) | 3.13923368 |
| 103 | leukocyte cell-cell adhesion (GO:0007159) | 3.11874556 |
| 104 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.11398600 |
| 105 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.11185859 |
| 106 | positive regulation of isotype switching (GO:0045830) | 3.07338655 |
| 107 | leukocyte degranulation (GO:0043299) | 3.06608917 |
| 108 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.06579050 |
| 109 | positive regulation of macrophage differentiation (GO:0045651) | 3.05903609 |
| 110 | regulation of regulatory T cell differentiation (GO:0045589) | 3.05555689 |
| 111 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.01879460 |
| 112 | response to host (GO:0075136) | 3.01809537 |
| 113 | response to host defenses (GO:0052200) | 3.01809537 |
| 114 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.01809537 |
| 115 | response to type I interferon (GO:0034340) | 3.01800514 |
| 116 | natural killer cell activation (GO:0030101) | 3.00914238 |
| 117 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.00840151 |
| 118 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.00530844 |
| 119 | type I interferon signaling pathway (GO:0060337) | 2.98246804 |
| 120 | cellular response to type I interferon (GO:0071357) | 2.98246804 |
| 121 | lymph node development (GO:0048535) | 2.96744988 |
| 122 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.96684404 |
| 123 | response to protozoan (GO:0001562) | 2.95368424 |
| 124 | regulation of mast cell degranulation (GO:0043304) | 2.94932575 |
| 125 | microglial cell activation (GO:0001774) | 2.93504600 |
| 126 | regulation of B cell mediated immunity (GO:0002712) | 2.93453276 |
| 127 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92641340 |
| 128 | leukocyte homeostasis (GO:0001776) | 2.90764968 |
| 129 | macrophage activation (GO:0042116) | 2.90650556 |
| 130 | natural killer cell differentiation (GO:0001779) | 2.90569198 |
| 131 | negative regulation of innate immune response (GO:0045824) | 2.89246700 |
| 132 | T cell differentiation (GO:0030217) | 2.87971351 |
| 133 | positive regulation of tolerance induction (GO:0002645) | 2.87541317 |
| 134 | regulation of isotype switching (GO:0045191) | 2.87445256 |
| 135 | defense response to protozoan (GO:0042832) | 2.87195220 |
| 136 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.87055618 |
| 137 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.86716966 |
| 138 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.86359126 |
| 139 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.85367177 |
| 140 | neutrophil mediated immunity (GO:0002446) | 2.85151135 |
| 141 | myeloid dendritic cell differentiation (GO:0043011) | 2.84746986 |
| 142 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.84489076 |
| 143 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.83491322 |
| 144 | positive regulation of B cell mediated immunity (GO:0002714) | 2.83491322 |
| 145 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.83451485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.03793459 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.75263715 |
| 3 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.69471335 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.52861146 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.84208104 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.69557490 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.14755364 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.12267881 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.03849168 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.97333807 |
| 11 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.92275949 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.92182464 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.91996215 |
| 14 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.88333342 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.81943471 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.81729956 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 2.81263026 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.76604035 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.66987784 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.65919785 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.52932335 |
| 22 | * MAF_26560356_Chip-Seq_TH1_Human | 2.51695552 |
| 23 | * MYB_26560356_Chip-Seq_TH1_Human | 2.36130896 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.36032213 |
| 25 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.34970571 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34542478 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.32189588 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31699432 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.29788656 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23688422 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.14166759 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 2.11346870 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08862328 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.07877815 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.06778088 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02563893 |
| 37 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01349215 |
| 38 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.96043417 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89391446 |
| 40 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84704715 |
| 41 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.83769829 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.81487464 |
| 43 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79354744 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75867263 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.75476195 |
| 46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.69218563 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.68802190 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.65530254 |
| 49 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.63100383 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59674450 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58671732 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.55854062 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54945379 |
| 54 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.52746648 |
| 55 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.48928194 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.48794990 |
| 57 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45937762 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.44723836 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.38298074 |
| 60 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.33179391 |
| 61 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.33149282 |
| 62 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31647714 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29841513 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29001657 |
| 65 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.28450458 |
| 66 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.27743355 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24846546 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20638243 |
| 69 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19091989 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19016842 |
| 71 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.18371472 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17713091 |
| 73 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16622493 |
| 74 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.14417816 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13749965 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12019574 |
| 77 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11440232 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10350276 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09481589 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08682884 |
| 81 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06612025 |
| 82 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.04414256 |
| 83 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00572224 |
| 84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99652843 |
| 85 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.99082599 |
| 86 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99002846 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98801545 |
| 88 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98528223 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97884752 |
| 90 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97331643 |
| 91 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.97201432 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96512980 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94150661 |
| 94 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.91108967 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91087259 |
| 96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90903346 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90518989 |
| 98 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90369750 |
| 99 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.90035646 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89994458 |
| 101 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.89612768 |
| 102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89569295 |
| 103 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89171516 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87098265 |
| 105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86588580 |
| 106 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.85881710 |
| 107 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85809729 |
| 108 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.83483970 |
| 109 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83359331 |
| 110 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.82341582 |
| 111 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81500292 |
| 112 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81114918 |
| 113 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.80770952 |
| 114 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.80130681 |
| 115 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.78589856 |
| 116 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.74399449 |
| 117 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.73957244 |
| 118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73656273 |
| 119 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.72624371 |
| 120 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.71569185 |
| 121 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.71089802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.15092319 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.15038284 |
| 3 | MP0005671_abnormal_response_to | 4.01453572 |
| 4 | MP0000685_abnormal_immune_system | 3.47179867 |
| 5 | MP0001800_abnormal_humoral_immune | 3.22113124 |
| 6 | MP0009785_altered_susceptibility_to | 3.09007020 |
| 7 | MP0002396_abnormal_hematopoietic_system | 3.07822719 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.89617822 |
| 9 | MP0005387_immune_system_phenotype | 2.87403179 |
| 10 | MP0001790_abnormal_immune_system | 2.87403179 |
| 11 | * MP0002420_abnormal_adaptive_immunity | 2.85338515 |
| 12 | * MP0001819_abnormal_immune_cell | 2.81630826 |
| 13 | MP0002723_abnormal_immune_serum | 2.80488473 |
| 14 | * MP0002398_abnormal_bone_marrow | 2.77584782 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.75754113 |
| 16 | MP0003436_decreased_susceptibility_to | 2.73752983 |
| 17 | MP0005025_abnormal_response_to | 2.71044825 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.56534650 |
| 19 | * MP0000716_abnormal_immune_system | 2.43353010 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.39433275 |
| 21 | MP0002419_abnormal_innate_immunity | 2.34923317 |
| 22 | * MP0000689_abnormal_spleen_morphology | 2.31270606 |
| 23 | MP0002405_respiratory_system_inflammati | 2.30413776 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.28472836 |
| 25 | * MP0002722_abnormal_immune_system | 2.26613371 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.25391209 |
| 27 | MP0003724_increased_susceptibility_to | 2.22052810 |
| 28 | MP0001873_stomach_inflammation | 2.20684071 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.14776854 |
| 30 | MP0002006_tumorigenesis | 2.13593519 |
| 31 | * MP0000703_abnormal_thymus_morphology | 2.12447422 |
| 32 | * MP0002429_abnormal_blood_cell | 2.07779932 |
| 33 | MP0001853_heart_inflammation | 2.05796639 |
| 34 | MP0004808_abnormal_hematopoietic_stem | 2.03447854 |
| 35 | MP0003303_peritoneal_inflammation | 1.96609191 |
| 36 | MP0004510_myositis | 1.94197208 |
| 37 | MP0006082_CNS_inflammation | 1.88953553 |
| 38 | MP0003866_abnormal_defecation | 1.86557990 |
| 39 | MP0004947_skin_inflammation | 1.86415522 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.85687457 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.81318217 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.81318217 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.81260302 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.79704261 |
| 45 | MP0002933_joint_inflammation | 1.65463849 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.63469490 |
| 47 | MP0005075_abnormal_melanosome_morpholog | 1.61687889 |
| 48 | MP0005451_abnormal_body_composition | 1.52270599 |
| 49 | MP0000490_abnormal_crypts_of | 1.42847803 |
| 50 | MP0000858_altered_metastatic_potential | 1.41078974 |
| 51 | MP0008260_abnormal_autophagy | 1.28945056 |
| 52 | MP0008469_abnormal_protein_level | 1.28391958 |
| 53 | MP0009278_abnormal_bone_marrow | 1.24450951 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.18673271 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.17304977 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.16619173 |
| 57 | MP0005310_abnormal_salivary_gland | 1.14616749 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.05322497 |
| 59 | MP0003448_altered_tumor_morphology | 1.02481701 |
| 60 | MP0010094_abnormal_chromosome_stability | 1.01844716 |
| 61 | MP0001986_abnormal_taste_sensitivity | 1.01471750 |
| 62 | MP0000015_abnormal_ear_pigmentation | 1.00039411 |
| 63 | MP0002095_abnormal_skin_pigmentation | 0.97503747 |
| 64 | MP0004883_abnormal_blood_vessel | 0.92965788 |
| 65 | MP0004381_abnormal_hair_follicle | 0.89693651 |
| 66 | MP0002132_abnormal_respiratory_system | 0.87836469 |
| 67 | MP0006054_spinal_hemorrhage | 0.87757683 |
| 68 | MP0001851_eye_inflammation | 0.87724410 |
| 69 | MP0003045_fibrosis | 0.84966354 |
| 70 | MP0003077_abnormal_cell_cycle | 0.81603923 |
| 71 | MP0008004_abnormal_stomach_pH | 0.81147045 |
| 72 | MP0000604_amyloidosis | 0.81059329 |
| 73 | MP0003693_abnormal_embryo_hatching | 0.78013096 |
| 74 | MP0003690_abnormal_glial_cell | 0.76888092 |
| 75 | MP0005390_skeleton_phenotype | 0.76690339 |
| 76 | MP0001663_abnormal_digestive_system | 0.76284798 |
| 77 | MP0000343_altered_response_to | 0.76076002 |
| 78 | MP0009763_increased_sensitivity_to | 0.76057964 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 0.75593027 |
| 80 | MP0008007_abnormal_cellular_replicative | 0.75271354 |
| 81 | MP0005164_abnormal_response_to | 0.74453975 |
| 82 | MP0005023_abnormal_wound_healing | 0.73793571 |
| 83 | MP0002009_preneoplasia | 0.73131559 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.70527518 |
| 85 | MP0005058_abnormal_lysosome_morphology | 0.70469954 |
| 86 | * MP0009764_decreased_sensitivity_to | 0.69375182 |
| 87 | MP0002998_abnormal_bone_remodeling | 0.66972081 |
| 88 | MP0008057_abnormal_DNA_replication | 0.66362348 |
| 89 | MP0009840_abnormal_foam_cell | 0.65722602 |
| 90 | MP0003943_abnormal_hepatobiliary_system | 0.65679308 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.63931701 |
| 92 | MP0005166_decreased_susceptibility_to | 0.62831385 |
| 93 | MP0003828_pulmonary_edema | 0.62760943 |
| 94 | MP0002693_abnormal_pancreas_physiology | 0.61095256 |
| 95 | MP0010352_gastrointestinal_tract_polyps | 0.61092167 |
| 96 | MP0008058_abnormal_DNA_repair | 0.59238581 |
| 97 | * MP0000313_abnormal_cell_death | 0.57758766 |
| 98 | MP0000249_abnormal_blood_vessel | 0.53992120 |
| 99 | MP0000477_abnormal_intestine_morphology | 0.53970921 |
| 100 | MP0008874_decreased_physiological_sensi | 0.53845448 |
| 101 | MP0003091_abnormal_cell_migration | 0.52593081 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 0.50984364 |
| 103 | MP0003566_abnormal_cell_adhesion | 0.50301293 |
| 104 | MP0003279_aneurysm | 0.48242885 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.48007208 |
| 106 | MP0004130_abnormal_muscle_cell | 0.47701413 |
| 107 | MP0005076_abnormal_cell_differentiation | 0.47595414 |
| 108 | MP0008873_increased_physiological_sensi | 0.47424826 |
| 109 | MP0003221_abnormal_cardiomyocyte_apopto | 0.47261546 |
| 110 | MP0003795_abnormal_bone_structure | 0.47018226 |
| 111 | MP0002254_reproductive_system_inflammat | 0.46558607 |
| 112 | MP0005381_digestive/alimentary_phenotyp | 0.46086697 |
| 113 | * MP0009765_abnormal_xenobiotic_induced | 0.45730492 |
| 114 | MP0000609_abnormal_liver_physiology | 0.45420169 |
| 115 | MP0001191_abnormal_skin_condition | 0.45189758 |
| 116 | MP0000598_abnormal_liver_morphology | 0.44292079 |
| 117 | MP0004147_increased_porphyrin_level | 0.43185602 |
| 118 | MP0003111_abnormal_nucleus_morphology | 0.43134900 |
| 119 | MP0003806_abnormal_nucleotide_metabolis | 0.41857272 |
| 120 | MP0003075_altered_response_to | 0.41045735 |
| 121 | MP0003453_abnormal_keratinocyte_physiol | 0.41020917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.00665462 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.00169114 |
| 3 | Recurrent bronchitis (HP:0002837) | 4.89201758 |
| 4 | Chronic otitis media (HP:0000389) | 4.86959246 |
| 5 | IgM deficiency (HP:0002850) | 4.81400591 |
| 6 | Abnormality of T cell number (HP:0011839) | 4.78208275 |
| 7 | Myositis (HP:0100614) | 4.54125360 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.50684669 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.46005958 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.37622779 |
| 11 | Thrombocytosis (HP:0001894) | 4.26049585 |
| 12 | Abnormality of T cells (HP:0002843) | 4.22289308 |
| 13 | Recurrent viral infections (HP:0004429) | 4.21518983 |
| 14 | Severe combined immunodeficiency (HP:0004430) | 4.18548779 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 4.10548362 |
| 16 | Combined immunodeficiency (HP:0005387) | 3.92155179 |
| 17 | Thyroiditis (HP:0100646) | 3.91352995 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.75654460 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.75654460 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.71118256 |
| 21 | Nasal polyposis (HP:0100582) | 3.71109559 |
| 22 | Stomatitis (HP:0010280) | 3.69759148 |
| 23 | Agammaglobulinemia (HP:0004432) | 3.61613172 |
| 24 | Meningitis (HP:0001287) | 3.61308890 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.60958738 |
| 26 | IgG deficiency (HP:0004315) | 3.56443055 |
| 27 | Lymphopenia (HP:0001888) | 3.39983760 |
| 28 | B lymphocytopenia (HP:0010976) | 3.39302236 |
| 29 | Abnormality of B cell number (HP:0010975) | 3.39302236 |
| 30 | Abnormality of the nasal mucosa (HP:0000433) | 3.37910410 |
| 31 | Abnormality of T cell physiology (HP:0011840) | 3.31294013 |
| 32 | Pustule (HP:0200039) | 3.30024259 |
| 33 | Chronic diarrhea (HP:0002028) | 3.29235031 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 3.28227680 |
| 35 | Recurrent skin infections (HP:0001581) | 3.27489348 |
| 36 | Abnormality of eosinophils (HP:0001879) | 3.26762454 |
| 37 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.24035027 |
| 38 | Inflammation of the large intestine (HP:0002037) | 3.13194324 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 3.11634439 |
| 40 | Optic neuritis (HP:0100653) | 3.11634439 |
| 41 | Gastrointestinal inflammation (HP:0004386) | 3.09731526 |
| 42 | Petechiae (HP:0000967) | 3.09346768 |
| 43 | Urticaria (HP:0001025) | 3.08115452 |
| 44 | Leukocytosis (HP:0001974) | 3.07274958 |
| 45 | Vasculitis (HP:0002633) | 3.04946710 |
| 46 | Orchitis (HP:0100796) | 3.03232119 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.99925284 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.97229717 |
| 49 | Obstructive lung disease (HP:0006536) | 2.95627986 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95627986 |
| 51 | Cellulitis (HP:0100658) | 2.92181014 |
| 52 | Recurrent sinusitis (HP:0011108) | 2.90944893 |
| 53 | Eosinophilia (HP:0001880) | 2.90456003 |
| 54 | Hypoplasia of the thymus (HP:0000778) | 2.89586844 |
| 55 | Epistaxis (HP:0000421) | 2.78453486 |
| 56 | Bronchitis (HP:0012387) | 2.78023694 |
| 57 | Encephalitis (HP:0002383) | 2.76483014 |
| 58 | Granulocytopenia (HP:0001913) | 2.74246929 |
| 59 | Chronic sinusitis (HP:0011109) | 2.70627510 |
| 60 | Lymphoma (HP:0002665) | 2.68863783 |
| 61 | Abnormality of the fingertips (HP:0001211) | 2.65817084 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.63644515 |
| 63 | Arterial thrombosis (HP:0004420) | 2.62054797 |
| 64 | Gastrointestinal stroma tumor (HP:0100723) | 2.60908578 |
| 65 | Gangrene (HP:0100758) | 2.60348377 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 2.59595388 |
| 67 | Increased IgE level (HP:0003212) | 2.57635430 |
| 68 | Episodic fever (HP:0001954) | 2.56499346 |
| 69 | Anorexia (HP:0002039) | 2.55029298 |
| 70 | Hemoptysis (HP:0002105) | 2.52743144 |
| 71 | Verrucae (HP:0200043) | 2.50068205 |
| 72 | Papilloma (HP:0012740) | 2.50068205 |
| 73 | IgA deficiency (HP:0002720) | 2.50054172 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.49964159 |
| 75 | Colitis (HP:0002583) | 2.49742145 |
| 76 | Keratoconjunctivitis sicca (HP:0001097) | 2.46241291 |
| 77 | Hypochromic anemia (HP:0001931) | 2.46213421 |
| 78 | Autoimmune hemolytic anemia (HP:0001890) | 2.42539384 |
| 79 | Chest pain (HP:0100749) | 2.42273124 |
| 80 | Gingivitis (HP:0000230) | 2.41790296 |
| 81 | Pulmonary infiltrates (HP:0002113) | 2.38691210 |
| 82 | Abnormality of the pleura (HP:0002103) | 2.38210722 |
| 83 | Abnormality of the prostate (HP:0008775) | 2.33084013 |
| 84 | Gingival bleeding (HP:0000225) | 2.32290532 |
| 85 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.28873756 |
| 86 | Hypergammaglobulinemia (HP:0010702) | 2.28323711 |
| 87 | Joint swelling (HP:0001386) | 2.28245346 |
| 88 | Periodontitis (HP:0000704) | 2.27527516 |
| 89 | Amaurosis fugax (HP:0100576) | 2.25182476 |
| 90 | Aplastic anemia (HP:0001915) | 2.24051454 |
| 91 | Interstitial pulmonary disease (HP:0006530) | 2.23905345 |
| 92 | Basal cell carcinoma (HP:0002671) | 2.23894393 |
| 93 | Keratoconjunctivitis (HP:0001096) | 2.20493285 |
| 94 | Slow saccadic eye movements (HP:0000514) | 2.19009288 |
| 95 | Skin ulcer (HP:0200042) | 2.13696879 |
| 96 | Hypochromic microcytic anemia (HP:0004840) | 2.13553390 |
| 97 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.12700242 |
| 98 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.12700242 |
| 99 | Abnormality of glycolipid metabolism (HP:0010969) | 2.12700242 |
| 100 | Abnormal platelet function (HP:0011869) | 2.10702481 |
| 101 | Impaired platelet aggregation (HP:0003540) | 2.10702481 |
| 102 | Glomerulopathy (HP:0100820) | 2.10368311 |
| 103 | Gastrointestinal infarctions (HP:0005244) | 2.09943124 |
| 104 | Abnormal platelet volume (HP:0011876) | 2.08804471 |
| 105 | Increased cerebral lipofuscin (HP:0011813) | 2.07057273 |
| 106 | Poikiloderma (HP:0001029) | 2.06085132 |
| 107 | Sepsis (HP:0100806) | 2.05659300 |
| 108 | Fatigue (HP:0012378) | 2.04231547 |
| 109 | Keratitis (HP:0000491) | 2.03675916 |
| 110 | Polyneuropathy (HP:0001271) | 2.03572037 |
| 111 | Acute hepatic failure (HP:0006554) | 2.02766979 |
| 112 | Increased IgM level (HP:0003496) | 2.02496541 |
| 113 | Increased serum ferritin (HP:0003281) | 2.00334834 |
| 114 | Skin rash (HP:0000988) | 1.99637276 |
| 115 | Premature loss of primary teeth (HP:0006323) | 1.99007475 |
| 116 | Emphysema (HP:0002097) | 1.96456617 |
| 117 | Restrictive lung disease (HP:0002091) | 1.96435383 |
| 118 | Osteomyelitis (HP:0002754) | 1.95049788 |
| 119 | Loss of speech (HP:0002371) | 1.94003020 |
| 120 | Pulmonary embolism (HP:0002204) | 1.93326581 |
| 121 | Acute myeloid leukemia (HP:0004808) | 1.93243683 |
| 122 | Papilledema (HP:0001085) | 1.92763125 |
| 123 | Abnormal number of erythroid precursors (HP:0012131) | 1.92333280 |
| 124 | Amyloidosis (HP:0011034) | 1.91816332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.49345758 |
| 2 | TXK | 4.43904050 |
| 3 | JAK3 | 3.36807376 |
| 4 | ZAP70 | 2.98896083 |
| 5 | PRPF4B | 2.91615121 |
| 6 | BTK | 2.54682001 |
| 7 | BLK | 2.40898470 |
| 8 | TEC | 2.39199821 |
| 9 | KIT | 2.38743871 |
| 10 | ITK | 2.35580727 |
| 11 | TYK2 | 2.23757101 |
| 12 | STK10 | 2.22865497 |
| 13 | IKBKE | 2.05514919 |
| 14 | SYK | 2.05352076 |
| 15 | NME2 | 2.03577193 |
| 16 | EEF2K | 1.94101131 |
| 17 | IRAK4 | 1.85969012 |
| 18 | TBK1 | 1.81183108 |
| 19 | MAP3K14 | 1.80458284 |
| 20 | GRK6 | 1.79786133 |
| 21 | CSF1R | 1.76756633 |
| 22 | LCK | 1.73034107 |
| 23 | JAK1 | 1.71769964 |
| 24 | NLK | 1.62067468 |
| 25 | FGFR4 | 1.60593011 |
| 26 | MAP3K12 | 1.50724594 |
| 27 | TGFBR2 | 1.50267311 |
| 28 | HCK | 1.45587090 |
| 29 | FLT3 | 1.44747259 |
| 30 | FES | 1.43135850 |
| 31 | MAP3K3 | 1.40796054 |
| 32 | KDR | 1.39908071 |
| 33 | FGR | 1.39120361 |
| 34 | CSK | 1.30319052 |
| 35 | MAP3K10 | 1.29241712 |
| 36 | PKN2 | 1.28636819 |
| 37 | MAP2K3 | 1.27766874 |
| 38 | BMPR2 | 1.23912305 |
| 39 | CLK1 | 1.19619433 |
| 40 | IKBKB | 1.17591433 |
| 41 | LRRK2 | 1.17005803 |
| 42 | LYN | 1.16689186 |
| 43 | MAP3K1 | 1.16429764 |
| 44 | FGFR3 | 1.15559935 |
| 45 | PIM1 | 1.15521270 |
| 46 | MAP3K13 | 1.14427224 |
| 47 | TAOK3 | 1.11778629 |
| 48 | TAOK2 | 1.04119323 |
| 49 | MARK3 | 1.02877101 |
| 50 | IRAK1 | 1.01815960 |
| 51 | RIPK4 | 0.95536773 |
| 52 | TNK2 | 0.95501702 |
| 53 | TGFBR1 | 0.88950082 |
| 54 | JAK2 | 0.88740817 |
| 55 | PIM2 | 0.86547286 |
| 56 | RPS6KA4 | 0.79345168 |
| 57 | KSR2 | 0.78154522 |
| 58 | SIK3 | 0.78011176 |
| 59 | IRAK2 | 0.77911147 |
| 60 | SIK2 | 0.76621610 |
| 61 | YES1 | 0.75825812 |
| 62 | TESK2 | 0.75565172 |
| 63 | CAMKK2 | 0.74971890 |
| 64 | IRAK3 | 0.74897854 |
| 65 | MAPK7 | 0.72288870 |
| 66 | PRKCQ | 0.71798976 |
| 67 | CDC42BPA | 0.69201097 |
| 68 | CHUK | 0.67641309 |
| 69 | MAP3K11 | 0.64617856 |
| 70 | CDK4 | 0.64610051 |
| 71 | CAMKK1 | 0.63315199 |
| 72 | ERN1 | 0.63208831 |
| 73 | EPHB1 | 0.62557017 |
| 74 | GRK7 | 0.62349446 |
| 75 | PDK1 | 0.61430718 |
| 76 | SMG1 | 0.61369042 |
| 77 | MST4 | 0.59794243 |
| 78 | PRKD2 | 0.59702580 |
| 79 | MAP3K7 | 0.57366742 |
| 80 | MAPK4 | 0.55801873 |
| 81 | NEK9 | 0.54499474 |
| 82 | RAF1 | 0.54495262 |
| 83 | PIK3CG | 0.54480935 |
| 84 | MATK | 0.52679925 |
| 85 | RPS6KB2 | 0.52456578 |
| 86 | HIPK2 | 0.51181773 |
| 87 | PDPK1 | 0.50351101 |
| 88 | CDK12 | 0.50235629 |
| 89 | PRKCH | 0.48468124 |
| 90 | TAOK1 | 0.48429747 |
| 91 | MAPK11 | 0.48099438 |
| 92 | STK4 | 0.46310139 |
| 93 | PTK6 | 0.45691777 |
| 94 | MAPKAPK3 | 0.43480483 |
| 95 | RPS6KA6 | 0.43464708 |
| 96 | CDC7 | 0.41800164 |
| 97 | STK24 | 0.41795240 |
| 98 | TRPM7 | 0.41596099 |
| 99 | MAP3K5 | 0.41354597 |
| 100 | MAP2K6 | 0.41174601 |
| 101 | MAP3K8 | 0.39448160 |
| 102 | CDK9 | 0.38538305 |
| 103 | MAPKAPK2 | 0.37595216 |
| 104 | SGK3 | 0.36337513 |
| 105 | STK11 | 0.35179069 |
| 106 | MAP3K2 | 0.35055427 |
| 107 | MAP2K2 | 0.34844501 |
| 108 | PASK | 0.34731445 |
| 109 | EPHA3 | 0.34242461 |
| 110 | SIK1 | 0.33659906 |
| 111 | MAPK12 | 0.33316344 |
| 112 | TRIB3 | 0.33269721 |
| 113 | PRKCD | 0.33204811 |
| 114 | RPS6KC1 | 0.32584095 |
| 115 | RPS6KL1 | 0.32584095 |
| 116 | RET | 0.31621405 |
| 117 | FYN | 0.29988731 |
| 118 | VRK1 | 0.29770188 |
| 119 | MAPK3 | 0.29557043 |
| 120 | ABL1 | 0.28860279 |
| 121 | CDK6 | 0.28739465 |
| 122 | DYRK1B | 0.28139848 |
| 123 | NUAK1 | 0.27410041 |
| 124 | SCYL2 | 0.26126362 |
| 125 | MARK2 | 0.26003327 |
| 126 | CDK19 | 0.25780980 |
| 127 | NEK2 | 0.24986008 |
| 128 | CDK8 | 0.24565165 |
| 129 | MYLK | 0.24403361 |
| 130 | IGF1R | 0.23788508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.12557426 |
| 2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.89013277 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.75080909 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.73743357 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.59624617 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.56226638 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.55146087 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.51461443 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46126847 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.44974565 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.34467302 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.12159609 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 1.97782856 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.96331943 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.86871204 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.80039164 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.79228879 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.74682918 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.69164654 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.64835084 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.64245679 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59359349 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53918953 |
| 24 | Shigellosis_Homo sapiens_hsa05131 | 1.42194548 |
| 25 | Mismatch repair_Homo sapiens_hsa03430 | 1.41750380 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35349885 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.35242055 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.34537380 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34499695 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31493241 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31459845 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27729186 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26306034 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26279514 |
| 35 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23555418 |
| 36 | Base excision repair_Homo sapiens_hsa03410 | 1.20450242 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.18491608 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.15077536 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.12469513 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.11018888 |
| 41 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.09837632 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.09828999 |
| 43 | Malaria_Homo sapiens_hsa05144 | 1.09196964 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.06833430 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 1.03980615 |
| 46 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.03215166 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97877167 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97841926 |
| 49 | Asthma_Homo sapiens_hsa05310 | 0.97439311 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97031376 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96463609 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 0.96265317 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95590228 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95098578 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.93295674 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.92644724 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91587386 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81463704 |
| 59 | Homologous recombination_Homo sapiens_hsa03440 | 0.80318013 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78257823 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78064047 |
| 62 | Spliceosome_Homo sapiens_hsa03040 | 0.77991720 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77512962 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76076981 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74144763 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74102216 |
| 67 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.72989334 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69325722 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69271604 |
| 70 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68300636 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.67301301 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66244170 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63773707 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63677319 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63157745 |
| 76 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62192795 |
| 77 | RNA degradation_Homo sapiens_hsa03018 | 0.61537517 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61033749 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54044810 |
| 80 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.53595799 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51854306 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50274986 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49513792 |
| 84 | Cell cycle_Homo sapiens_hsa04110 | 0.48805457 |
| 85 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48615278 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47475721 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47030728 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46636234 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46373324 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.45564373 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45258756 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44970619 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44583870 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43814927 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43305223 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42175021 |
| 97 | Proteasome_Homo sapiens_hsa03050 | 0.41247368 |
| 98 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.40938189 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40800300 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.39562142 |
| 101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39413918 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39202623 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39145000 |
| 104 | Prostate cancer_Homo sapiens_hsa05215 | 0.39032968 |
| 105 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37251702 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35752627 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33569060 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.33196391 |
| 109 | RNA polymerase_Homo sapiens_hsa03020 | 0.32976649 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32702706 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31777158 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31694907 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30958703 |
| 114 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29618938 |
| 115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29458403 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29097378 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28891537 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.28554707 |
| 119 | Sulfur relay system_Homo sapiens_hsa04122 | 0.28512692 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.28222130 |
| 121 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28128991 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26046993 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24833824 |
| 124 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.24363822 |
| 125 | Glioma_Homo sapiens_hsa05214 | 0.20888654 |
| 126 | Long-term potentiation_Homo sapiens_hsa04720 | 0.18450133 |

